Skip to content

Danaher

NYSE: DHR · USD

Danaher revenue82

Quarterly and annual revenue from company filings.

Business drivers

Business lines and operating measures.

Operating Segments · Life Sciences Segment revenue

Reported quarterly Operating Segments · Life Sciences Segment revenue. Quarterly figures · USD

Operating Segments · Life Sciences Segment revenue. Reported quarterly Operating Segments · Life Sciences Segment revenue. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Sep 25, 2026From Jun 27, 20261,865,000,000Filed Oct 21, 2026
Jun 26, 2026From Mar 28, 20261,879,000,000Filed Jul 21, 2026
Mar 27, 2026From Jan 1, 20261,737,000,000Filed Apr 21, 2026
Sep 26, 2025From Jun 28, 20251,792,000,000Filed Oct 21, 2026
Jun 27, 2025From Mar 29, 20251,777,000,000Filed Jul 21, 2026
Mar 28, 2025From Jan 1, 20251,680,000,000Filed Apr 21, 2026

Operating Segments · Biotechnology Segment revenue

Reported quarterly Operating Segments · Biotechnology Segment revenue. Quarterly figures · USD

Operating Segments · Biotechnology Segment revenue. Reported quarterly Operating Segments · Biotechnology Segment revenue. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Sep 25, 2026From Jun 27, 20261,807,000,000Filed Oct 21, 2026
Jun 26, 2026From Mar 28, 20261,920,000,000Filed Jul 21, 2026
Mar 27, 2026From Jan 1, 20261,797,000,000Filed Apr 21, 2026
Sep 26, 2025From Jun 28, 20251,798,000,000Filed Oct 21, 2026
Jun 27, 2025From Mar 29, 20251,850,000,000Filed Jul 21, 2026
Mar 28, 2025From Jan 1, 20251,612,000,000Filed Apr 21, 2026

Operating Segments · Diagnostics Segment revenue

Reported quarterly Operating Segments · Diagnostics Segment revenue. Quarterly figures · USD

Operating Segments · Diagnostics Segment revenue. Reported quarterly Operating Segments · Diagnostics Segment revenue. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Sep 25, 2026From Jun 27, 20262,882,000,000Filed Oct 21, 2026
Jun 26, 2026From Mar 28, 20262,466,000,000Filed Jul 21, 2026
Mar 27, 2026From Jan 1, 20262,417,000,000Filed Apr 21, 2026
Sep 26, 2025From Jun 28, 20252,463,000,000Filed Oct 21, 2026
Jun 27, 2025From Mar 29, 20252,309,000,000Filed Jul 21, 2026
Mar 28, 2025From Jan 1, 20252,449,000,000Filed Apr 21, 2026

Independent series; they may overlap and do not form an additive breakdown.

  • The supplied proposals contain revenue disclosures rather than physical operating measures.

Products & projects

Masimo

Masimo develops and produces monitoring technologies, which include innovative measurements, sensors and patient monitors, serving primarily healthcare customers and is now part of the Company’s Diagnostics segment.

Filed · source for Masimo

Revenue history

USD millions · Fiscal periods
Jul 3, 2009 through Sep 25, 2026

Quarterly data

Danaher quarterly financial data in USD millions. FY denotes the company's fiscal year. YTD covers reported quarters only.
Fiscal quarterEndedTotal revenueUSD millions
FY 2026 Q3Sep 25, 20266,554, +4.6% versus FY 2026 Q2
FY 2026 Q2Jun 26, 20266,265, +5.3% versus FY 2026 Q1
FY 2026 Q1Mar 27, 20265,951, −13.0% versus FY 2025 Q4
FY 2025 Q4Dec 31, 20256,838, +13.0% versus FY 2025 Q3
FY 2025 Q3Sep 26, 20256,053, +2.0% versus FY 2025 Q2
FY 2025 Q2Jun 27, 20255,936, +3.4% versus FY 2025 Q1
FY 2025 Q1Mar 28, 20255,741, −12.2% versus FY 2024 Q4
FY 2024 Q4Dec 31, 20246,538, +12.8% versus FY 2024 Q3
FY 2024 Q3Sep 27, 20245,798, +1.0% versus FY 2024 Q2
FY 2024 Q2Jun 28, 20245,743, −0.9% versus FY 2024 Q1
FY 2024 Q1Mar 29, 20245,796, −9.5% versus FY 2023 Q4
FY 2023 Q4Dec 31, 20236,405, −6.8% versus FY 2023 Q3
FY 2023 Q3Sep 29, 20236,873, −4.0% versus FY 2023 Q2
FY 2023 Q2Jun 30, 20237,157, −0.1% versus FY 2023 Q1
FY 2023 Q1Mar 31, 20237,167, +0.5% versus FY 2022 Q4
FY 2022 Q4Dec 31, 20227,134, −6.9% versus FY 2022 Q3
FY 2022 Q3Sep 30, 20227,663, −1.1% versus FY 2022 Q2
FY 2022 Q2Jul 1, 20227,751, +0.8% versus FY 2022 Q1
FY 2022 Q1Apr 1, 20227,688, −5.6% versus FY 2021 Q4
FY 2021 Q4Dec 31, 20218,148, +12.7% versus FY 2021 Q3
FY 2021 Q3Oct 1, 20217,229, +0.2% versus FY 2021 Q2
FY 2021 Q2Jul 2, 20217,218, +5.2% versus FY 2021 Q1
FY 2021 Q1Apr 2, 20216,858, +1.4% versus FY 2020 Q4
FY 2020 Q4Dec 31, 20206,760.3, +14.9% versus FY 2020 Q3
FY 2020 Q3Oct 2, 20205,883.2, +11.1% versus FY 2020 Q2
FY 2020 Q2Jul 3, 20205,297.4, +22.0% versus FY 2020 Q1
FY 2020 Q1Apr 3, 20204,343.1, −10.8% versus FY 2019 Q4
FY 2019 Q4Dec 31, 20194,868.4, −3.4% versus FY 2019 Q3
FY 2019 Q3Sep 27, 20195,037.3, −2.3% versus FY 2019 Q2
FY 2019 Q2Jun 28, 20195,156.6, +5.7% versus FY 2019 Q1
FY 2019 Q1Mar 29, 20194,879.9, −9.0% versus FY 2018 Q4
FY 2018 Q4Dec 31, 20185,363.5, +10.5% versus FY 2018 Q3
FY 2018 Q3Sep 28, 20184,853.1, −2.6% versus FY 2018 Q2
FY 2018 Q2Jun 29, 20184,981, +6.1% versus FY 2018 Q1
FY 2018 Q1Mar 30, 20184,695.4, −7.7% versus FY 2017 Q4
FY 2017 Q4Dec 31, 20175,085.7, +12.3% versus FY 2017 Q3
FY 2017 Q3Sep 29, 20174,528.2, +0.4% versus FY 2017 Q2
FY 2017 Q2Jun 30, 20174,510.1, +7.2% versus FY 2017 Q1
FY 2017 Q1Mar 31, 20174,205.7, −8.3% versus FY 2016 Q4
FY 2016 Q4Dec 31, 20164,584.3, +10.9% versus FY 2016 Q3
FY 2016 Q3Sep 30, 20164,132.1, −28.6% versus FY 2016 Q2
FY 2016 Q2Jul 1, 20165,785, +7.4% versus FY 2016 Q1
FY 2016 Q1Apr 1, 20165,387.2, −8.5% versus FY 2015 Q4
FY 2015 Q4Dec 31, 20155,884.8, +17.1% versus FY 2015 Q3
FY 2015 Q3Oct 2, 20155,023.4, −2.0% versus FY 2015 Q2
FY 2015 Q2Jul 3, 20155,127.1, +5.2% versus FY 2015 Q1
FY 2015 Q1Apr 3, 20154,873.3, −10.0% versus FY 2014 Q4
FY 2014 Q4Dec 31, 20145,417.2, +11.2% versus FY 2014 Q3
FY 2014 Q3Sep 26, 20144,870.3, −1.9% versus FY 2014 Q2
FY 2014 Q2Jun 27, 20144,963.6, +6.5% versus FY 2014 Q1
FY 2014 Q1Mar 28, 20144,662.7, −11.5% versus FY 2013 Q4
FY 2013 Q4Dec 31, 20135,266.7, +12.8% versus FY 2013 Q3
FY 2013 Q3Sep 27, 20134,669.1, −1.4% versus FY 2013 Q2
FY 2013 Q2Jun 28, 20134,737.5, +6.6% versus FY 2013 Q1
FY 2013 Q1Mar 29, 20134,444.7, −10.7% versus FY 2012 Q4
FY 2012 Q4Dec 31, 20124,975.2, +12.7% versus FY 2012 Q3
FY 2012 Q3Sep 28, 20124,415.543, −3.0% versus FY 2012 Q2
FY 2012 Q2Jun 29, 20124,553.459, +5.5% versus FY 2012 Q1
FY 2012 Q1Mar 30, 20124,316.22, −8.5% versus FY 2011 Q4
FY 2011 Q4Dec 31, 20114,716.6, +4.4% versus FY 2011 Q3
FY 2011 Q3Sep 30, 20114,518.089, +21.7% versus FY 2011 Q2
FY 2011 Q2Jul 1, 20113,711.674, +10.9% versus FY 2011 Q1
FY 2011 Q1Apr 1, 20113,345.702, −7.3% versus FY 2010 Q4
FY 2010 Q4Dec 31, 20103,609.3, +13.1% versus FY 2010 Q3
FY 2010 Q3Oct 1, 20103,190.193, −3.6% versus FY 2010 Q2
FY 2010 Q2Jul 2, 20103,310.921, +7.1% versus FY 2010 Q1
FY 2010 Q1Apr 2, 20103,092.22, −1.3% versus FY 2009 Q4
FY 2009 Q4Dec 31, 20093,132.9, +13.9% versus FY 2009 Q3
FY 2009 Q3Oct 2, 20092,750.693, +2.9% versus FY 2009 Q2
FY 2009 Q2Jul 3, 20092,673.609, Change unavailable versus FY 2009 Q1
Sources and definitions

Figures from official company filings and financial reports, in the reported currency. FY identifies the fiscal year; the end date identifies the calendar period. Last checked Oct 19, 2026.

Annual values come from annual filings. Historical quarters retain their reporting basis; rounding and reclassifications can make their sum differ from the annual figure. YTD sums the available fiscal quarters and compares the same quarters of the previous fiscal year.

Missing values are shown as unavailable. Fourth quarters use reported values where available, otherwise the annual amount less the matching nine-month amount.

Total revenue
Reported consolidated revenue from the issuer filing. Each observation identifies its accounting concept; bank net revenue is net of interest expense when that concept is reported.
Annual and quarterly differences
  • FY 2010 · Total revenue: annual 13,202.602, quarter sum 13,202.634 USD millions.
  • FY 2011 · Total revenue: annual 16,090.54, quarter sum 16,292.065 USD millions.
  • FY 2012 · Total revenue: annual 18,260.4, quarter sum 18,260.422 USD millions.
  • FY 2015 · Total revenue: annual 20,563.1, quarter sum 20,908.6 USD millions.
  • FY 2016 · Total revenue: annual 16,882.4, quarter sum 19,888.6 USD millions.
  • FY 2019 · Total revenue: annual 17,911.1, quarter sum 19,942.2 USD millions.
  • FY 2022 · Total revenue: annual 31,471, quarter sum 30,236 USD millions.
  • FY 2023 · Total revenue: annual 23,890, quarter sum 27,602 USD millions.